1. A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. (April 2022) Authors: Tagliamento, Marco; Bironzo, Paolo; Curcio, Hubert; De Luca, Emmanuele; Pignataro, Daniele; Rapetti, Simonetta G.; Audisio, Marco; Bertaglia, Valentina; Paratore, Chiara; Bungaro, Maristella; Olmetto, Emanuela; Artusio, Elisa; Reale, Maria Lucia; Zichi, Clizia; Capelletto, Enrica; Carnio, Simona;... Journal: Critical reviews in oncology/hematology Issue: Volume 172(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial. (October 2022) Authors: Felip, Enriqueta; Smit, Egbert F.; Molina-Vila, Miguel A.; Dafni, Urania; Massuti, Bartomeu; Berghmans, Thierry; de Marinis, Filippo; Passiglia, Francesco; Dingemans, Anne-Marie C.; Cobo, Manuel; Viteri, Santiago; Britschgi, Christian; Cuffe, Sinead; Provencio, Mariano; Merkelbach-Bruse, Sabine; ... Journal: Lung cancer Issue: Volume 172(2022) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-angiogenic drugs for second-line treatment of NSCLC patients: just new pawns on the chessboard?. (2nd January 2016) Authors: Bronte, Giuseppe; Passiglia, Francesco; Galvano, Antonio; Russo, Antonio Journal: Expert opinion on biological therapy Issue: Volume 16:Number 1(2016:Jan.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗